Related Experiment Video
Updated: Sep 5, 2025

Generation of Lymph Node-fat Pad Chimeras for the Study of Lymph Node Stromal Cell Origin
Published on: December 16, 2013
The transcription factor RUNX2 drives the generation of human NK cells and promotes tissue residency
Sigrid Wahlen1,2, Filip Matthijssens2,3, Wouter Van Loocke2,3
1Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.
Abstract:
Natural killer (NK) cells are innate lymphocytes that eliminate virus-infected and cancer cells by cytotoxicity and cytokine secretion. In addition to circulating NK cells, distinct tissue-resident NK subsets have been identified in various organs. Although transcription factors regulating NK cell development and function have been extensively studied in mice, the role of RUNX2 in these processes has not been investigated, neither in mice nor in human. Here, by manipulating RUNX2 expression with either knockdown or overexpression in human haematopoietic stem cell-based NK cell differentiation cultures, combined with transcriptomic and ChIP-sequencing analyses, we established that RUNX2 drives the generation of NK cells, possibly through induction of IL-2Rβ expression in NK progenitor cells. Importantly, RUNX2 promotes tissue residency in human NK cells. Our findings have the potential to improve existing NK cell-based cancer therapies and can impact research fields beyond NK cell biology, since tissue-resident subsets have also been described in other lymphocyte subpopulations.
Insights
RUNX2 drives the generation of natural killer (NK) cells and promotes their tissue residency. This discovery may enhance NK cell-based cancer therapies by targeting this key transcription factor.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- Natural killer (NK) cells are crucial innate lymphocytes for eliminating virus-infected and cancer cells.
- Distinct tissue-resident NK cell subsets exist, but the regulators of their development and function are not fully understood.
- The role of the transcription factor RUNX2 in NK cell biology remains uninvestigated in both mice and humans.
Purpose of the Study:
- To investigate the role of RUNX2 in the development and function of human NK cells.
- To determine if RUNX2 influences NK cell generation and tissue residency.
- To explore the potential therapeutic implications of RUNX2 in NK cell-based cancer treatments.
Main Methods:
- Human hematopoietic stem cell-based NK cell differentiation cultures were used.
- RUNX2 expression was manipulated via knockdown and overexpression.
- Transcriptomic and ChIP-sequencing analyses were performed to understand molecular mechanisms.
Main Results:
- RUNX2 was found to drive the generation of NK cells, potentially by inducing IL-2Rβ expression in NK progenitor cells.
- RUNX2 was demonstrated to promote tissue residency in human NK cells.
- The study provides new insights into the molecular regulation of NK cell development and tissue homing.
Conclusions:
- RUNX2 is a key transcription factor regulating human NK cell generation and promoting tissue residency.
- Targeting RUNX2 could offer novel strategies for improving NK cell-based cancer immunotherapies.
- These findings have broader implications for understanding tissue-resident lymphocytes beyond NK cells.
Related Concept Videos
Inheritance of Chromatin Structures
Lineage Commitment
Methods of Nuclear Reprogramming
Chromatin Position Affects Gene Expression
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...
Co-activators and Co-repressors
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...

